After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Beam Therapeutics Inc (BEAM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.24, or 0.78%, to $31.00. The Beam Therapeutics Inc has recorded 91,488 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results.
Stocks Info
Beam Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $30.76 and fluctuated between $31.09 as its day high and $27.59 as its day low. The current market capitalization of Beam Therapeutics Inc is $2.51B. A total of 3.53 million shares were traded on the day, compared to an average of 1.17M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, BEAM has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 3,836 shares. Over the last 12 months, there were 20 BUYs and 28 SELLs from insiders. Insiders purchased 341,624 shares during that period but sold 408,343.
In the most recent transaction, Simon Amy sold 3,448 shares of BEAM for 18.70 per share on Oct 30. After the transaction, the Chief Medical Officer now owns 65,469 company shares. In a previous transaction on Oct 02, Bellon Christine sold 388 shares at 22.85 per share. BEAM shares that Chief Legal Officer owns now total 82,402.
Among the insiders who sold shares, Ciaramella Giuseppe disposed of 1,206 shares on Jul 24 at a per-share price of $32.01. This resulted in the President and CSO holding 48,250 shares of BEAM after the transaction. In another insider transaction, Ciaramella Giuseppe sold 155,324 shares at $32.06 per share on Jul 21. Company shares held by the President and CSO now total 48,250.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for BEAM in the last 3 months, the mean price target is $49.67 with high estimates of $95.00 and low estimates of $19.00. In terms of 52-week highs and lows, BEAM has a high of $51.60 and a low of $16.95.
As of this writing, BEAM has an earnings estimate of -$0.96 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of $1.21 per share and a lower estimate of -$1.46. The company reported an EPS of -$1.08 in the last quarter, which was 23.90% higher than expectations of -$1.42.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BEAM’s latest balance sheet shows that the firm has $965.65M in Cash & Short Term Investments as of fiscal 2021. There were $142.35M in debt and $213.44M in liabilities at the time. Its Book Value Per Share was $9.81, while its Total Shareholder’s Equity was $826.74M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BEAM is Buy with a score of 4.14.
